文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

昼夜节律功能障碍与阿尔茨海默病——最新综述

Circadian dysfunction and Alzheimer's disease - An updated review.

作者信息

Ahmad Faizan, Sachdeva Punya, Sarkar Jasmine, Izhaar Raafiah

机构信息

Department of Medical Elementology and Toxicology Jamia Hamdard University Delhi India.

Amity Institute of Neuropsychology and Neurosciences Amity University Noida Uttar Pradesh India.

出版信息

Aging Med (Milton). 2022 Aug 15;6(1):71-81. doi: 10.1002/agm2.12221. eCollection 2023 Mar.


DOI:10.1002/agm2.12221
PMID:36911088
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10000289/
Abstract

Alzheimer's disease (AD) is considered to be the most typical form of dementia that provokes irreversible cognitive impairment. Along with cognitive impairment, circadian rhythm dysfunction is a fundamental factor in aggravating AD. A link among circadian rhythms, sleep, and AD has been well-documented. The etiopathogenesis of circadian system disruptions and AD serves some general characteristics that also open up the possibility of viewing them as a mutually reliant path. In this review, we have focused on different factors that are related to circadian rhythm dysfunction. The various pathogenic factors, such as amyloid-beta, neurofibrillary tangles, oxidative stress, neuroinflammation, and circadian rhythm dysfunction may all contribute to AD. In this review, we also tried to focus on melatonin which is produced from the pineal gland and can be used to treat circadian dysfunction in AD. Aside from amyloid beta, tau pathology may have a notable influence on sleep. Conclusively, the center of this review is primarily based on the principal mechanistic complexities associated with circadian rhythm disruption, sleep deprivation, and AD, and it also emphasizes the potential therapeutic strategies to treat and prevent the progression of AD.

摘要

阿尔茨海默病(AD)被认为是引发不可逆认知障碍的最典型痴呆形式。除认知障碍外,昼夜节律功能障碍是加重AD的一个基本因素。昼夜节律、睡眠和AD之间的联系已有充分记录。昼夜节律系统紊乱与AD的发病机制具有一些共同特征,这也为将它们视为相互依存的路径提供了可能性。在这篇综述中,我们重点关注了与昼夜节律功能障碍相关的不同因素。各种致病因素,如β-淀粉样蛋白、神经原纤维缠结、氧化应激、神经炎症和昼夜节律功能障碍,都可能导致AD。在这篇综述中,我们还试图关注由松果体产生、可用于治疗AD昼夜节律功能障碍的褪黑素。除了β-淀粉样蛋白外,tau病理可能对睡眠有显著影响。总之,本综述主要围绕与昼夜节律紊乱、睡眠剥夺和AD相关的主要机制复杂性展开,同时也强调了治疗和预防AD进展的潜在治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/976b/10000289/8f91d4f4eb3c/AGM2-6-71-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/976b/10000289/090438f14bcb/AGM2-6-71-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/976b/10000289/7d43abb45e2b/AGM2-6-71-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/976b/10000289/8f91d4f4eb3c/AGM2-6-71-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/976b/10000289/090438f14bcb/AGM2-6-71-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/976b/10000289/7d43abb45e2b/AGM2-6-71-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/976b/10000289/8f91d4f4eb3c/AGM2-6-71-g004.jpg

相似文献

[1]
Circadian dysfunction and Alzheimer's disease - An updated review.

Aging Med (Milton). 2022-8-15

[2]
Circadian and sleep dysfunction in Alzheimer's disease.

Ageing Res Rev. 2020-4-16

[3]
Deciphering the Interacting Mechanisms of Circadian Disruption and Alzheimer's Disease.

Neurochem Res. 2021-7

[4]
Melatonin in Alzheimer's Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer's Neuropathology.

Mol Neurobiol. 2019-6-17

[5]
Pro: Alzheimer's disease and circadian dysfunction: chicken or egg?

Alzheimers Res Ther. 2012-8-13

[6]
The use of chronobiotics in the resynchronization of the sleep/wake cycle. Therapeutical application in the early phases of Alzheimer's disease.

Recent Pat Endocr Metab Immune Drug Discov. 2011-5

[7]
The role of sleep deprivation and circadian rhythm disruption as risk factors of Alzheimer's disease.

Front Neuroendocrinol. 2019-5-15

[8]
Decoding the Inter-Relationship between Sleep Disorders and Alzheimer's Disease Pathogenesis.

CNS Neurol Disord Drug Targets. 2021

[9]
Sleep-Wake Disorders in Alzheimer's Disease: A Review.

ACS Chem Neurosci. 2022-5-18

[10]
Pineal gland dysfunction in Alzheimer's disease: relationship with the immune-pineal axis, sleep disturbance, and neurogenesis.

Mol Neurodegener. 2019-7-11

引用本文的文献

[1]
Disrupting the Clock: Meta-Analysis of Irregular Night Shifts and Migraine, Proposing Shift Work Migraine Disorder with Chronobiology Strategies.

medRxiv. 2025-8-1

[2]
The Clock and the Brain: Circadian Rhythm and Alzheimer's Disease.

Curr Issues Mol Biol. 2025-7-15

[3]
Linkage of circadian rhythm disruptions with Alzheimer's disease and therapeutic interventions.

Acta Pharm Sin B. 2025-6

[4]
Exploring the relationship between mean performance and within-person variability on smartphone-based cognitive testing in adults across the lifespan.

NPP Digit Psychiatry Neurosci. 2025

[5]
White matter microstructure statistically mediates associations between circadian rest/activity rhythms and cognition in older adults.

Sleep Adv. 2025-5-5

[6]
Dual orexin receptor antagonists as promising therapeutics for Alzheimer's disease.

NPJ Biol Timing Sleep. 2025

[7]
The role of sleep in Alzheimer's disease: a mini review.

Front Neurosci. 2025-2-5

[8]
Disparate and shared transcriptomic signatures associated with cortical atrophy in genetic behavioral variant frontotemporal degeneration.

Mol Neurodegener. 2025-2-7

[9]
Melatonin Supplementation Alleviates Impaired Spatial Memory by Influencing Aβ Metabolism via γ-Secretase in the icvAβ Rat Model with Pinealectomy.

Int J Mol Sci. 2024-9-24

[10]
Exploring the most promising anti - Depressant drug targeting Microtubule Affinity Receptor Kinase 4 involved in Alzheimer's Disease through molecular docking and molecular dynamics simulation.

PLoS One. 2024

本文引用的文献

[1]
Glymphatic Dysfunction: A Bridge Between Sleep Disturbance and Mood Disorders.

Front Psychiatry. 2021-5-7

[2]
Elevated CLOCK and BMAL1 Contribute to the Impairment of Aerobic Glycolysis from Astrocytes in Alzheimer's Disease.

Int J Mol Sci. 2020-10-23

[3]
Glymphatic System Impairment in Alzheimer's Disease and Idiopathic Normal Pressure Hydrocephalus.

Trends Mol Med. 2020-3

[4]
Inhibition of REV-ERBs stimulates microglial amyloid-beta clearance and reduces amyloid plaque deposition in the 5XFAD mouse model of Alzheimer's disease.

Aging Cell. 2019-12-4

[5]
Author Correction: Inhibition of casein kinase 1δ/εimproves cognitive-affective behavior and reduces amyloid load in the APP-PS1 mouse model of Alzheimer's disease.

Sci Rep. 2019-10-17

[6]
Corrigendum to "Molecular mechanisms underlying protective role of quercetin in attenuating Alzheimer's disease" [Life Sci. 221 (2019) 109-119].

Life Sci. 2019-8-15

[7]
Melatonin in Alzheimer's Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer's Neuropathology.

Mol Neurobiol. 2019-6-17

[8]
Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease.

JCI Insight. 2017-8-17

[9]
The role of melatonin in the onset and progression of type 3 diabetes.

Mol Brain. 2017-8-1

[10]
A 50-Year Personal Journey: Location, Gene Expression, and Circadian Rhythms.

Cold Spring Harb Perspect Biol. 2017-12-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索